This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Donghui Cui
Introduction
Donghui Cui is a notable inventor based in Chalfont, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of oncological and immunological disorders. His work has led to the development of innovative compounds that have the potential to improve patient outcomes.
Latest Patents
Donghui Cui holds a patent for the invention titled 'N-(2-chloro-6-methylphenyl)-2-[[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites'. This invention focuses on the metabolites of the compound of formula (I), along with pharmaceutical compositions and methods for their use in treating various disorders.
Career Highlights
Cui is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from complex diseases.
Collaborations
Throughout his career, Donghui Cui has collaborated with esteemed colleagues, including Vinod Kumar Arora and Lisa Joy Christopher. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Donghui Cui's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Bristol-Myers Squibb Company highlight the importance of research in developing new treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile